Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces... Show more
a manufacturer of blood processing systems
Industry MedicalNursingServices
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| FLAO | 28.60 | 0.02 | +0.07% |
| AllianzIM US Equity 6M Flr5 Apr/Oct ETF | |||
| BOXX | 117.99 | 0.04 | +0.03% |
| Alpha Architect 1-3 Month Box ETF | |||
| FTMS | 9.91 | N/A | N/A |
| Franklin Short-Term Municipal Income ETF | |||
| ULTY | 26.50 | N/A | -0.01% |
| YieldMax Ultra Option Income Strat ETF | |||
| RSBY | 18.00 | -0.01 | -0.07% |
| Return Stacked Bonds & Futures Yield ETF | |||
A.I.dvisor indicates that over the last year, HAE has been loosely correlated with SRTS. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if HAE jumps, then SRTS could also see price increases.
| Ticker / NAME | Correlation To HAE | 1D Price Change % | ||
|---|---|---|---|---|
| HAE | 100% | -1.59% | ||
| SRTS - HAE | 44% Loosely correlated | -2.08% | ||
| PEN - HAE | 43% Loosely correlated | -0.41% | ||
| ECOR - HAE | 43% Loosely correlated | +9.29% | ||
| STE - HAE | 42% Loosely correlated | +0.14% | ||
| ATR - HAE | 41% Loosely correlated | +0.39% | ||
More | ||||
| Ticker / NAME | Correlation To HAE | 1D Price Change % |
|---|---|---|
| HAE | 100% | -1.59% |
| Health Services category (242 stocks) | 4% Poorly correlated | -0.15% |
| Medical/Nursing Services category (140 stocks) | 3% Poorly correlated | -0.25% |
HAE's Aroon Indicator triggered a bullish signal on August 26, 2026. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 196 similar instances where the Aroon Indicator showed a similar pattern. In of the 196 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at .
The Moving Average Convergence Divergence (MACD) for HAE just turned positive on July 28, 2026. Looking at past instances where HAE's MACD turned positive, the stock continued to rise in of 42 cases over the following month. The odds of a continued upward trend are .
Following a +2 3-day Advance, the price is estimated to grow further. Considering data from situations where HAE advanced for three days, in of 346 cases, the price rose further within the following month. The odds of a continued upward trend are .
The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 6 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 13 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where HAE declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
HAE broke above its upper Bollinger Band on August 18, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. HAE’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock slightly better than average.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.708) is normal, around the industry mean (11.133). P/E Ratio (50.725) is within average values for comparable stocks, (69.340). Projected Growth (PEG Ratio) (1.663) is also within normal values, averaging (3.915). HAE has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.017). P/S Ratio (3.626) is also within normal values, averaging (34.439).